24 results
6-K
EX-99.1
IPHA
Innate Pharma
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
the Company’s leadership and corporate governance with the appointment of two new Executive Board members. Arvind Sood, Executive Vice President (EVP
6-K
EX-99.1
IPHA
Innate Pharma
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
announced that it has strengthened the Company’s leadership and corporate governance with the appointment of two new Executive Board members. Arvind
6-K
IPHA
Innate Pharma
5 Jan 24
Innate Pharma S.a. 6-K
6:09am
4, 2024, Innate Pharma also announced that it has sought to strengthen the Company’s leadership and corporate governance with the appointment of two
6-K
EX-99.1
IPHA
Innate Pharma
4 Jan 24
Innate Pharma 6-K
6:00am
Exhibit 99.1
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Two new Executive Board members appointed … ” or the “Company”) today announced that it has strengthened the Company’s leadership and corporate governance with the appointment of two new Executive Board
6-K
EX-99.1
uatf4oiesu1 i3q
18 Dec 23
Innate Pharma S.a. 6-K
11:40am
20-F/A
EX-4.9
7qg9hw0wp 1set2mf4
20 Apr 23
Annual report (foreign) (amended)
8:47am
6-K
EX-99.1
8xu4a9uxem9g3e
16 Jun 21
Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
6:30am
6-K
EX-99.1
nauf hvz4
9 Feb 21
Innate Pharma Advances Lacutamab Clinical Development Program
6:30am
6-K
EX-99.1
e8u4wcmz36z 0laprjt
4 Feb 21
Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas
8:59am
20-F
m71qtfp3
24 Apr 20
Annual report (foreign)
10:43am
6-K
EX-99.1
iq07 5asd53
10 Mar 20
Current report (foreign)
6:30am
6-K
EX-99.1
uoivwdumjcgj p4g0t
10 Mar 20
Innate Pharma Reports Full Year 2019 Financial Results and Business Update
6:30am
424B4
yse2phc2w 9uf
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
1jmyze iqx7wlkax
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
EX-10.4
njoix1 bud3ef
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
f7q3vv
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.4
bbp8oc ucl
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
8ntaa
30 Aug 19
Draft registration statement (amended)
12:00am